ATLAS VENTURE ENTREPRENEURS FUND V LP's Net Worth
$617 Million
Who is ATLAS VENTURE ENTREPRENEURS FUND V LP?
ATLAS VENTURE ENTREPRENEURS FUND V LP has an estimated net worth of $617 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., Isilon Systems, Inc., Phase Forward Inc, ACHILLION PHARMACEUTICALS INC, NxStage Medical, Inc., MOMENTA PHARMACEUTICALS INC, and HELICOS BIOSCIENCES CORP.
SEC CIK
ATLAS VENTURE ENTREPRENEURS FUND V LP's CIK is 0001133807
Past Insider Trading and Trends
2004 was ATLAS VENTURE ENTREPRENEURS FUND V LP's most active year for acquiring shares with 45 total transactions. ATLAS VENTURE ENTREPRENEURS FUND V LP's most active month to acquire stocks was the month of May. 2005 was ATLAS VENTURE ENTREPRENEURS FUND V LP's most active year for disposing of shares, totalling 39 transactions. ATLAS VENTURE ENTREPRENEURS FUND V LP's most active month to dispose stocks was the month of May. 2007 saw ATLAS VENTURE ENTREPRENEURS FUND V LP paying a total of $2,999,997.00 for 2,987,766 shares, this is the most they've acquired in one year. In 2010 ATLAS VENTURE ENTREPRENEURS FUND V LP cashed out on 15,051,590 shares for a total of $472,764,088.82, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $169.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.84% | -183.00K |
$14.97 | -$2,729,560.81 | 2.49M |
Feb 23 - Feb 24
| |||
Form 4
| -33.33% | -1.34M |
—
|
—
| 2.67M |
Sep 29
| |||
Form 4
| +801.66% | 3.57M |
—
|
—
| 4.01M |
Jun 3
| |||
Form 4/A
|
∞
| 445K |
$6.00 | $2,670,000.00 | 445K |
May 27
| |||
Form 4
|
∞
| 445K |
$6.00 | $2,670,000.00 | 445K |
May 27 - Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Isilon Systems, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -12.82M |
$33.85 | -$433,858,496.50 |
0
|
Dec 17
| |||
Form 4
| -2.38% | -313.00K |
$20.07 | -$6,280,381.60 | 12.82M |
Aug 23 - Aug 24
| |||
Form 4
| -3.28% | -445.00K |
$17.52 | -$7,794,231.10 | 13.13M |
Aug 16 - Aug 18
| |||
Form 4
| -2.31% | -320.29K |
$17.97 | -$5,756,261.51 | 13.58M |
Aug 4 - Aug 6
| |||
Form 4
| -3.10% | -444.70K |
$17.93 | -$7,973,305.73 | 13.9M |
Jul 30 - Aug 3
| |||
Form 4
| -1.98% | -289.81K |
$17.40 | -$5,041,885.59 | 14.34M |
Jul 26 - Jul 27
| |||
Form 4
| -1.82% | -271.70K |
$14.48 | -$3,933,741.79 | 14.63M |
May 11 - May 13
| |||
Form 4
| -1.00% | -150.00K |
$14.17 | -$2,125,785.00 | 14.9M |
May 4 - May 5
| |||
Form 4
| +0.23% | 69.28K |
$3.40 | $233,317.78 | 30.1M |
Nov 13 - Nov 14
| |||
Form 4
| +0.30% | 135.9K |
$3.41 | $461,815.74 | 44.95M |
Nov 10 - Nov 12
| |||
Form 4
| +0.09% | 25.44K |
$3.45 | $87,506.63 | 29.69M |
Nov 6 - Nov 7
| |||
Form 4
| +0.14% | 42.81K |
$3.42 | $145,049.54 | 29.64M |
Nov 4 - Nov 5
| |||
Form 4
|
∞
| 14.78M |
—
|
—
| 14.78M |
Dec 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Phase Forward Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -36.45% | -1.25M |
—
|
—
| 2.18M |
Oct 10
| |||
Form 4
| -5.25% | -190.00K |
$8.97 | -$1,704,300.00 | 3.43M |
Sep 14
| |||
Form 4
| -1.87% | -138.29K |
$8.46 | -$1,169,767.24 | 7.24M |
Sep 9 - Sep 12
| |||
Form 4
| -1.46% | -111.71K |
$8.27 | -$924,300.52 | 7.52M |
Sep 7 - Sep 8
| |||
Form 4
| -1.15% | -45.00K |
$7.61 | -$342,450.00 | 3.87M |
Jun 14
| |||
Form 4
| -1.26% | -50.00K |
$6.93 | -$346,500.00 | 3.91M |
Jun 9
| |||
Form 4
| -1.28% | -154.62K |
$6.82 | -$1,054,507.00 | 11.89M |
Jun 6 - Jun 8
| |||
Form 4
| -10.82% | -500.00K |
$6.85 | -$3,425,000.00 | 4.12M |
Mar 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACHILLION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.97M |
—
|
—
| 1.97M |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NxStage Medical, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||